Drug companies were warned that the Trump administration is weighing linking US medicine prices to the lower amounts paid by other developed nations, Reuters reported Tuesday, citing two pharmaceutical company sources.

The policy is expected to come from the agency that oversees Medicare and Medicaid, the report said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 22.41, Change: +0.37, Percent Change: +1.67